The Manila Times18m
Nurix Announces U.S. FDA Orphan Drug Designation Granted to Bexobrutideg (NX-5948) for the Treatment of Waldenström Macroglobulinemia
Orphan Drug Designation follows positive Phase 1 data presented at the 12th International Workshop on Waldenström ...
Asian News International on MSN5h
Rifampicin drug used in TB treatment is expected to be commissioned later this year
The drug Rifampicin, which is used in serious bacterial infections, particularly Tuberculosis, is expected to be commissioned ...
Opinion: Drug pricing program provides essential services to underserved communities
The drug pricing program reveals systemic disparities in healthcare access and begins to address healthcare issues, ...
The common signs of endometriosis – as new treatment drug gets NHS approval
The drug will only be made available on the NHS for patients whose medical or surgical treatment for endometriosis has failed ...
Medscape29m
Significant Improvement in Psoriasis Observed With Novel Oral Drug Icotrokinra, in Phase 3 Trial
Adults taking the novel once-daily oral pill for plaque psoriasis had significantly higher rates of clear or almost clear ...
Stockton to receive another £2.5m grant money to help with drug and alcohol treatment and recovery
Stockton Council leaders spoke of the importance of the money to help with problems which had 'far-reaching' effects ...
From a contraceptive to an IVF treatment: These women's health drugs will become cheaper
A new treatment for a common painful condition and two other drugs will be made cheaper to improve access to treatment for ...
Drug market crisis in Seattle's University District prompts call for city intervention
An entrenched and escalating drug market is creating chronic public safety issues in Seattle’s University District, according ...
KIMT News 33d
Rochester could be affected by possible closure of statewide drug treatment provider
ST. PAUL, Minn. - The Minnesota Department of Human Services (DHS) is trying to ease concerns as a drug treatment provider ...
Fierce Biotech2h
Latigo saddles up with $150M to spur non-opioid pain drugs through the clinic
Latigo Biotherapeutics has whipped together a $150 million series B fundraising round to advance a pipeline of non-opioid ...
The Manila Times18m
Travere Therapeutics Submits sNDA to FDA for Approval of FILSPARI® (sparsentan) for the Treatment of FSGS
FILSPARI REMS: Due to the risk of hepatotoxicity and embryo-fetal toxicity, FILSPARI is available only through a restricted program called the FILSPARI REMS. Prescribers, patients, and pharmacies must ...
Senate Passes Bill to Make Penalties Permanent for Fentanyl-Related Drugs
The measure, which passed with bipartisan support and minor changes, now heads back to the House. It is just the second ...